natural-products-congress-world-pharma-congress-2017-posters

7 / 26

Page 58
Notes:
Volume 4, Issue 2 American Journal of Ethnomedicine
ISSN 2348-9502
Natural Products Congress & World Pharma Congress 2017
October 16-18, 2017
3rd World Congress on
NATURAL PRODUCTS CHEMISTRY AND RESEARCH
&
12th WORLD PHARMA CONGRESS
October 16-18, 2017 Budapest, Hungary
Need for orphan drug provisions in India
Nagaraja S, H V Raghunandan and Balamuralidhara V
JSS University, India
An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition. India
currently has no regulations for orphan drug manufacturing or selling. It is estimated that 72,611,605 people are affected
by rare diseases in India (2011). About 6000 to 8000 rare diseases, mostly genetic in nature have been identified. Recent
news about orphan diseases in India was tracked and the data was compiled. No specific primary medication is available for
orphan disease in India. However, secondary medications are being used for preventive treatment of these diseases. A group of
pharmacologists requested the Indian government to enact the Orphan Drug Act in India at a conference held by the Indian
Drug Manufacturers Association in 2001. However, this was a dead end as no such provisions have been initiated by the
government till date. It is necessary on the part of the Indian government and regulatory bodies to implement such provisions
and bring about a whirlwind of change by enacting provisions related to orphan drugs.
Nagaraja S et al., American Journal of Ethnomedicine, 4:2
DOI: 10.21767/2348-9502-C1-003